Anti-Depressants vs Physiotherapy in Management of Fibromyalgia
Effect of Anti-Depressants vs Physiotherapy in Management of Fibromyalgia Syndrome: What Predicts a Clinical Benefit?
1 other identifier
interventional
175
1 country
1
Brief Summary
To compare the efficacy of physiotherapy and anti-depressants in disability reduction in patients of Fibromyalgia syndrome.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for phase_3
Started Mar 2006
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2006
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2007
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2008
CompletedFirst Submitted
Initial submission to the registry
June 23, 2008
CompletedFirst Posted
Study publicly available on registry
June 25, 2008
CompletedJuly 4, 2008
June 1, 2008
1.8 years
June 23, 2008
June 25, 2008
Conditions
Outcome Measures
Primary Outcomes (1)
Reduction in FIQ score from the baseline
Two years
Secondary Outcomes (2)
Reduction in Tender point score
Two years
Reduction in Brief psychiatric rating score
Two Years
Study Arms (2)
2
EXPERIMENTALanti-depressants
1
EXPERIMENTALphysiotherapy
Interventions
Eligibility Criteria
You may qualify if:
- Patient's between 18-60 yrs, belonging to either sex. With symptoms of chronic muscular pain of at least 12 weeks (that may or may not be consecutive) who fulfill the American College of Rheumatology (ACR) criteria for the diagnosis of Fibromyalgia
You may not qualify if:
- Patients of age group more than 60 yrs and below 18 years
- Pregnant or lactating females.
- Patients with a history of trauma.
- Patients with severe co morbid illness which prevents physical activity (for example, cardiovascular problems)
- Patients with the presence of specific medical disorders which require immediate treatment (for example, fractures, infectious diseases),
- Patients with associated neurological abnormality
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Mahatma Gandhi Institute of Medical Sciences
Sevāgrām, Maharashtra, 442102, India
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
June 23, 2008
First Posted
June 25, 2008
Study Start
March 1, 2006
Primary Completion
December 1, 2007
Study Completion
April 1, 2008
Last Updated
July 4, 2008
Record last verified: 2008-06